Indian scientists bring almost 200 technology solutions to fight Covid-19, Indian scientists have so far developed around 200 COVID-19 technologies, including tracking and testing solutions.
Research on treatment or prevention, such as repurposing existing medicines, has also been used to treat existing patients or to prevent the infection of primary health personnel. The list includes a number of Apps such as GoCoronaGo, Sampark-O-Meter, KAWACH and the most popular Aarogya Setu – a loosely-based application based on Singapore’s proven ‘TraceTogether.’
The Council of Scientific and Industrial Research (CSIR), the premier body, published on Wednesday a compendium on Indian technologies summarizing the emerging field of technology under 3 Ts – Tracking, Testing, and Treatment — in order to address the threat of the Covid19 disease. A day after it had shared solutions and research on vaccines and drug repurposing. Shekhar C Mande, CSIR Director-General, said that “this is very timely, to be of benefit to micro, medium enterprises MSMEs, startups and the public at large.”
In preparation of a compendium of most relevant and evolving indigenous technological innovations, including in research, produced by the National Research Development Corporation (NRDC) of the Ministry of Science and Technology. Many of the NRDC’s technologies were also approved by the ICMR. They will, therefore, be a ready reference for policymakers, industry, business people, researchers and scientists.
This compendium includes information provided by various government bodies and key institutions, including ICMR, the biotechnology department, CSIR, DRDO, IIT, IISc and the science and technology department. The Compendium includes a rapid test kit, RT-PCR detection kit, paper strip test testing, a quick antibody test and drug identification through computing, as well as different types of handheld digital IR thermometers and tracing application models.
The nasal gel, UV-tech sanitising trumpet, low-cost 3D face shield, bodysuits, anti-microbial materials and disinfection drones are included in the protective solution. The research team from different institutions on the vaccine front is trying to develop and test variants of SARS-CoV-2 spike glycoprotein as vaccine candidates.
With regard to anti-viral drugs, the Compendium has included few WHO drugs that are accepted as key drugs in India for coronavirus treatment, like Hydroxychloroquine (HCQ), Remdesivir, Falaviparavir and Lupinivir.
The pharmaceutical company Cipla, with its collaboration with scientists of the CSIR Indian Institute of Chemical Technology, has already announced that it is rapidly tracking its wide variety of respiratory, antaxis, anti-viral and HIV drugs in order to face the challenges arising from coronavirus.
In the meantime, a Delhi-based institution under the Department of Biotechnology (DBT), as part of a variety of efforts at government scientific bodies to identify solutions for the management of Covid-19, is exploring natural plant products that could be anti-viral in nature, in order to find drugs against the SARS-CoV-2 virus.
In collaboration with the Faridabad Regional Center for Biotechnology, the potential activities of the identified molecules against Covid-19 are being tested. Others are also involved in vaccine development programs, including the National Institute of Immunology (NII). In order to collect Covid-19 patients x27 from about 8 clinic centres all across Delhi-NCR, the DBT has formed the COVID-9 Research Consortium.
Indian scientists bring almost 200 technology solutions to fight Covid-19
Follow us for more news across industries!